Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

NCT03904563 PHASE2 COMPLETED

This prospective phase II study is to determine the efficacy and safety of bevacizumab maintenance therapy after concurrent chemoradiotherapy in locally advanced lung adenocarcinoma

Details

Lead sponsor	Sun Yat-sen University
Phase	PHASE2
Status	COMPLETED
Enrolment	27
Start date	Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Dec 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Lung Adenocarcinoma

Interventions

• Bevacizumab
• chest radiation
• concurrent chemotherapy

Countries

China